Bell Ceremonies

MBX Biosciences Rings the Nasdaq Stock Market Opening Bell

Published

MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Kent Hawryluk, President & Chief Executive Officer, rings the Opening Bell.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now